These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6605536)

  • 1. Distinct recognition sites on histocompatibility antigens for antibodies and cytotoxic T lymphocytes.
    Hämmerling GJ; Kuon W; Rüsch E
    Prog Clin Biol Res; 1983; 132B():375-85. PubMed ID: 6605536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-induced changes in class I heavy chains alter allorecognition.
    Bluestone JA; Kaliyaperumal A; Jameson S; Miller S; Dick R
    J Immunol; 1993 Oct; 151(8):3943-53. PubMed ID: 8409378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
    Rüsch E; Kuon W; Hämmerling GJ
    Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
    [No Abstract]   [Full Text] [Related]  

  • 6. Spatially distinct allodeterminants of the H-2Kk molecule as detected by monoclonal anti-H-2 antibodies.
    Ozato K; Henkart P; Jensen C; Sachs DH
    J Immunol; 1981 May; 126(5):1780-5. PubMed ID: 6163817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of T cell receptors specific for recognition of class IB antigens.
    Lowen LC; Aldrich CJ; Forman J
    J Immunol; 1993 Dec; 151(11):6155-65. PubMed ID: 8245458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactive monoclonal antibodies select Kd molecules with different peptide profiles.
    Noun G; Reboul M; Abastado JP; Jaulin C; Kourilsky P; Pla M
    J Immunol; 1996 Sep; 157(6):2455-61. PubMed ID: 8805645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones.
    Bonneau RH; Salvucci LA; Johnson DC; Tevethia SS
    Virology; 1993 Jul; 195(1):62-70. PubMed ID: 7686314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differences in recognition of peptides of the MHC H-2Kb molecule between cytotoxic T-lymphocytes, memory cells, and T-suppressor cells, specific for alloantigen H-2Kb].
    Brondz BD; Kazanskiĭ DB; Chernysheva AD; Pavlova TN; Ivanov VS
    Mol Biol (Mosk); 1996; 30(1):156-62. PubMed ID: 8714132
    [No Abstract]   [Full Text] [Related]  

  • 12. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.
    Luescher IF; Vivier E; Layer A; Mahiou J; Godeau F; Malissen B; Romero P
    Nature; 1995 Jan; 373(6512):353-6. PubMed ID: 7830771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
    Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
    Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
    Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
    Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural changes in class I MHC molecules influencing recognition by allo- or self + TNP-reactive cytotoxic T-cell clones and by monoclonal antibodies.
    Davignon JL; Albert F; Boyer C; Hua C; Buferne M; Guimezanes A; Schmitt-Verhulst AM
    Transplant Proc; 1983 Dec; 15(4):2080-5. PubMed ID: 6608811
    [No Abstract]   [Full Text] [Related]  

  • 20. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.